UBS lowered the firm’s price target on Equifax (EFX) to $230 from $270 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EFX:
- Equifax: Resilient Data Moat and FICO-Driven Upside Undervalued, Supporting Buy Rating
- Equifax: Strong Operating Momentum and Capital Returns Underscore Attractive Buy-Rated Valuation Despite Regulatory Uncertainty
- Equifax price target lowered to $215 from $240 at Barclays
- Equifax price target lowered to $200 from $242 at Clear Street
- Equifax: Strong Q4 Beat, Rebounding Government Segment, and Undervalued Long-Term Earnings Power Support Buy Rating